Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) occurs in approximately 10% to 25% of all patients with breast cancer and is associated with poor prognosis. Neo-adjuvant chemotherapy has been reported to produce a higher pathologic complete response (pCR) rate in TNBC. If pCR is achieved, patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yiqing, Zhu, Li, Li, Yafen, Ji, Jun, Li, Jianfang, Yuan, Fei, Wang, Dengbin, Chen, Weiguo, Huang, Ou, Chen, Xiaosong, Wu, Jiayi, Shen, Kunwei, Loo, Wings TY, Chow, Louis WC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Proceedings
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445857/
https://www.ncbi.nlm.nih.gov/pubmed/23046633
http://dx.doi.org/10.1186/1479-5876-10-S1-S4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445857/
https://www.ncbi.nlm.nih.gov/pubmed/23046633
http://dx.doi.org/10.1186/1479-5876-10-S1-S4

Ejemplares similares